Related Experiment Video
Updated: May 24, 2026
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
PI3King on MYCN to improve neuroblastoma therapeutics
Michael D Hogarty1, John M Maris
1Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA 19104, USA. hogartym@email.chop.edu
Abstract:
MYCN is an oncogenic driver of childhood neuroblastoma, a frequently lethal pediatric tumor. In a recent paper in Science Translational Medicine, Chanthery and colleagues demonstrate that PI3K inhibition leads to the dual therapeutic benefits of enhanced MYCN degradation and loss of a paracrine angiogenic signal mediated by MYCN.
Insights
PI3K inhibition offers a dual therapy for neuroblastoma by promoting MYCN protein destruction and reducing tumor-promoting angiogenesis. This approach targets a key driver of this aggressive childhood cancer.
Area of Science:
- Oncology
- Molecular Biology
- Pediatric Cancer Research
Background:
- MYCN is a critical oncogenic driver in neuroblastoma, a highly aggressive pediatric cancer.
- Neuroblastoma's lethality is often linked to MYCN's role in tumor progression and angiogenesis.
Discussion:
- This study investigates the therapeutic potential of PI3K inhibition in neuroblastoma.
- The research explores how PI3K inhibition impacts MYCN protein levels and angiogenic signaling.
Key Insights:
- PI3K inhibition effectively enhances the degradation of the MYCN oncoprotein.
- Targeting PI3K also diminishes a crucial paracrine angiogenic signal mediated by MYCN.
Outlook:
- Dual therapeutic strategies targeting MYCN degradation and angiogenesis show promise for neuroblastoma treatment.
- Further research into PI3K inhibitors could lead to novel therapeutic avenues for pediatric neuroblastoma.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015